Companies: 10,795·Total market cap: $144.5T
InspireMD, Inc.

InspireMD, Inc.

NSPRNASDAQHealthcare● Active
$0.82
$-0.06(-7.24%)
Market Cap$38234676
P/E Ratio
52W High$2.93
52W Low$0.8

InspireMD, Inc. (NSPR) Revenue

Annual & quarterly revenue history · segment & region breakdown

NSPR · revenue · updated Jun 9, 2026

Core revenue metrics

InspireMD, Inc. trailing twelve-month (TTM) revenue is $0.01B, an increase of 28.11% year-over-year from $0.01B in FY2025.

TTM revenue
$0.01B
4-quarter sum · USD
YoY growth
+28.11%
vs FY2025 $0.01B
Price / sales
3.52×
mktCap ÷ TTM rev
Revenue per day
$0M
Est. TTM ÷ 365
Revenue / employee
$128K
85 employees
FY2025
$0.01B
FY2024
$0.01B
5Y CAGR
+14.8%
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · InspireMD, Inc. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

20252009 · Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
2025-12-31$0.01B+$0.00B+28.11%
2024-12-31$0.01B+$0.00B+12.96%
2023-12-31$0.01B+$0.00B+20.00%
2022-12-31$0.01B+$0.00B+15.04%
2021-12-31$0.00B+$0.00B+80.89%
2020-12-31$0.00B-$0.00B-33.22%
2019-12-31$0.00B+$0.00B+3.33%
2018-12-31$0.00B+$0.00B+30.42%
2017-12-31$0.00B+$0.00B+45.78%
2016-12-31$0.00B-$0.00B-18.01%
NSPR revenue by year · NSPR revenue history · NSPR annual revenue data

Revenue breakdown

Segment & Geography
By business segment
No segment data available for this period.
By geography
Total$0.01B
$0.00B45.2%
$0.00B15.8%
$0.00B13.7%
$0.00B13.7%
$0.00B11.5%
Data from InspireMD, Inc. annual 10-K filing · FY ending 2025-12-31
NSPR revenue breakdown · NSPR revenue by segment · NSPR revenue by region

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income InspireMD, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

InspireMD, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from InspireMD, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

NSPR revenue · 4 questions

NSPR's trailing twelve-month (TTM) revenue is $0.01B. That is an increase of 28.11% year-over-year from $0.01B in FY2025.

NSPR revenueNSPR annual revenuewhat is NSPR revenueNSPR TTM revenue

Source: FMP · InspireMD, Inc. SEC filings · GAAP · InspireMD, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026